CXCL12 and breast cancer: Raschioni et al. demonstrated that activation of the C-X-C chemokine receptor 4 (CXCR4)/CXCL12 pathway was associated with the presence of M2 TAMs in primary BC of the luminal B subtype, maintaining the invasiveness of BC cells [118].